JP Morgan Chase’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.8M | Buy |
473,300
+224,800
| +90% | +$18M | ﹤0.01% | 1745 |
|
|
2025
Q4 | $23.7M | Sell |
248,500
-6,800
| -3% | -$667K | ﹤0.01% | 1924 |
|
|
2025
Q3 | $24.9M | Buy |
255,300
+75,300
| +42% | +$7.8M | ﹤0.01% | 1915 |
|
|
2025
Q2 | $19.3M | Sell |
180,000
-24,400
| -12% | -$2.47M | ﹤0.01% | 1976 |
|
|
2025
Q1 | $20.6M | Buy |
204,400
+53,000
| +35% | +$5.34M | ﹤0.01% | 1907 |
|
|
2024
Q4 | $13.5M | Hold |
151,400
| – | – | ﹤0.01% | 2415 |
|
|
2024
Q3 | $12.7M | Buy |
151,400
+78,000
| +106% | +$6.15M | ﹤0.01% | 2402 |
|
|
2024
Q2 | $5.65M | Sell |
73,400
-37,300
| -34% | -$2.73M | ﹤0.01% | 2943 |
|
|
2024
Q1 | $7.58M | Buy |
110,700
+43,500
| +65% | +$2.8M | ﹤0.01% | 2737 |
|
|
2023
Q4 | $3.88M | Hold |
67,200
| – | – | ﹤0.01% | 3307 |
|
|
2023
Q3 | $3.55M | Buy |
67,200
+37,800
| +129% | +$1.98M | ﹤0.01% | 3087 |
|
|
2023
Q2 | $1.59M | Sell |
29,400
-206,200
| -88% | -$10.8M | ﹤0.01% | 3705 |
|
|
2023
Q1 | $11.8M | Buy |
235,600
+148,600
| +171% | +$7M | ﹤0.01% | 2141 |
|
|
2022
Q4 | $4.03M | Sell |
87,000
-355,100
| -80% | -$15.4M | ﹤0.01% | 3008 |
|
|
2022
Q3 | $17.1M | Buy |
442,100
+420,500
| +1,947% | +$16.9M | ﹤0.01% | 1692 |
|
|
2022
Q2 | $805K | Sell |
21,600
-826,900
| -97% | -$33.7M | ﹤0.01% | 4252 |
|
|
2022
Q1 | $37.6M | Buy |
848,500
+453,000
| +115% | +$19.6M | ﹤0.01% | 1330 |
|
|
2021
Q4 | $16.8M | Buy |
395,500
+376,800
| +2,015% | +$15.8M | ﹤0.01% | 1965 |
|
|
2021
Q3 | $811K | Sell |
18,700
-146,800
| -89% | -$6.49M | ﹤0.01% | 4453 |
|
|
2021
Q2 | $7.08M | Buy |
165,500
+161,500
| +4,038% | +$6.79M | ﹤0.01% | 2732 |
|
|
2021
Q1 | $155K | Buy |
+4,000
| New | +$151K | ﹤0.01% | 5244 |
|
|
2020
Q1 | – | Sell |
-91,500
| Closed | -$4.14M | – | 5314 |
|
|
2019
Q4 | $4.14M | Buy |
91,500
+18,200
| +25% | +$762K | ﹤0.01% | 2835 |
|
|
2019
Q3 | $2.98M | Buy |
+73,300
| New | +$3.11M | ﹤0.01% | 3134 |
|
|
2019
Q1 | – | Sell |
-95,000
| Closed | -$3.36M | – | 5768 |
|
|
2018
Q4 | $3.36M | Hold |
95,000
| – | – | ﹤0.01% | 2877 |
|
|
2018
Q3 | $3.66M | Sell |
95,000
-492,800
| -84% | -$17.2M | ﹤0.01% | 3003 |
|
|
2018
Q2 | $19.2M | Buy |
587,800
+442,800
| +305% | +$13.4M | ﹤0.01% | 1619 |
|
|
2018
Q1 | $3.96M | Buy |
145,000
+50,000
| +53% | +$1.36M | ﹤0.01% | 2768 |
|
|
2017
Q4 | $2.35M | Buy |
+95,000
| New | +$2.62M | ﹤0.01% | 3222 |
|
|
2017
Q3 | – | Sell |
-41,800
| Closed | -$1.16M | – | 4968 |
|
|
2017
Q2 | $1.16M | Sell |
41,800
-11,400
| -21% | -$303K | ﹤0.01% | 3352 |
|
|
2017
Q1 | $1.32M | Sell |
53,200
-307,600
| -85% | -$7.48M | ﹤0.01% | 3273 |
|
|
2016
Q4 | $7.8M | Buy |
+360,800
| New | +$7.87M | ﹤0.01% | 2096 |
|
|
2015
Q2 | – | Sell |
-1,200
| Closed | -$21K | – | 4024 |
|
|
2015
Q1 | $21K | Sell |
1,200
-34,000
| -97% | -$537K | ﹤0.01% | 3983 |
|
|
2014
Q4 | $466K | Sell |
35,200
-67,500
| -66% | -$863K | ﹤0.01% | 3698 |
|
|
2014
Q3 | $43.7M | Buy |
+102,700
| New | +$1.29M | 0.01% | 964 |
|
|
2014
Q1 | – | Sell |
-700
| Closed | -$8K | – | 3614 |
|
|
2013
Q4 | $8K | Sell |
700
-100
| -13% | -$1.18K | ﹤0.01% | 4038 |
|
|
2013
Q3 | $9K | Sell |
800
-500
| -38% | -$5.41K | ﹤0.01% | 4331 |
|
|
2013
Q2 | $12K | Buy |
+1,300
| New | +$11K | ﹤0.01% | 4336 |
|
Other funds holding BSX
VCM
VPM
JP Morgan Chase's BSX Position: Q1 2026 in Review
JP Morgan Chase increased its Boston Scientific (BSX) stake by 31% in Q1 2026, buying an estimated $638M and bringing the position to 33,350,157 shares worth $2.1B. The position accounts for 0.13% of the portfolio, ranked #152.
JP Morgan Chase first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.18B in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- JP Morgan Chase held 33,350,157 shares of Boston Scientific worth $2.1B as of Q1 2026.
- JP Morgan Chase bought 7,977,271 Boston Scientific shares in Q1 2026, an estimated $638M.
- Boston Scientific made up 0.13% of JP Morgan Chase's portfolio in Q1 2026, its #152 holding.
- JP Morgan Chase first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- JP Morgan Chase's Boston Scientific position peaked at $3.18B in Q1 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.